Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Case Study: Treating Metastatic Pancreatic NETs

February 28th 2014

Utilizing Everolimus and Sunitinib in pNETs

February 28th 2014

RADIANT-3 Trial: Everolimus for Patients With pNETs

February 28th 2014

Everolimus in Pancreatic Neuroendocrine Tumors

February 28th 2014

Role of Somatostatin Analogs for Patients With pNETs

February 28th 2014

Alkylating Agents in Pancreatic Neuroendocrine Tumors

February 28th 2014

Treatment of Neuroendocrine Tumor Liver Metastases

February 28th 2014

Pathologic Classification of Neuroendocrine Tumors

February 28th 2014

Pancreatic Neuroendocrine Tumor Diagnosis Challenges

February 28th 2014

Integrating Genetic Counseling Into an Oncology Practice Can Benefit High-Risk Families

February 26th 2014

Genetic counseling-including testing and risk assessment-is one of the most rapidly growing areas of oncology and has become the standard of care for patients with a personal and family history of breast, ovary, or colon cancer.

Final Thoughts on the Treatment of mCRC

February 26th 2014

Panitumumab, Regorafenib, and Ziv-aflibercept in mCRC

February 26th 2014

Third-Line Treatment Options for mCRC

February 26th 2014

First- and Second-Line Treatment of mCRC in Specific Populations

February 26th 2014

Current Trends in the Treatment of CRC

February 26th 2014

Tumor Profiling in Patients With mCRC

February 26th 2014

New Therapies in Development for mCRC

February 26th 2014

Role of the VEGF Inhibitor Aflibercept in mCRC

February 26th 2014

Role of the Multikinase Inhibitor Regorafenib in mCRC

February 26th 2014

Considerations When Selecting an EGFR Inhibitor in mCRC

February 26th 2014